Chronic Headache

Differentiating between chronic tension-type headache (CTTH), chronic migraine (CM), and chronic cluster headache (CCH) requires careful evaluation of headache characteristics, frequency, and associated symptoms. CTTH presents as bilateral, non-pulsating pain of mild to moderate intensity, lasting 30 minutes to 7 days, without significant aggravation by routine physical activity and typically lacking nausea or photophobia/phonophobia. CM involves headache attacks lasting 4-72 hours if untreated, featuring pulsating quality, moderate to severe intensity, unilateral location, aggravation by or causing avoidance of routine physical activity, and associated nausea and/or photophobia/phonophobia. CCH manifests as severe, strictly unilateral orbital, supraorbital, or temporal pain lasting 15-180 minutes, occurring in clusters with a frequency of one every other day to eight per day. CCH attacks are accompanied by at least one ipsilateral autonomic symptom such as lacrimation, conjunctival injection, nasal congestion, rhinorrhea, forehead and facial sweating, miosis, ptosis, or eyelid edema. Consider implementing a headache diary to aid in diagnosis by tracking headache frequency, duration, intensity, and associated symptoms. Explore how utilizing validated screening tools, like the ID Migraine and the HIT-6, can further refine your assessment. Learn more about specific diagnostic criteria outlined in the International Classification of Headache Disorders, 3rd edition (ICHD-3).

Managing chronic tension-type headache (CTTH) in primary care involves a multimodal approach encompassing both pharmacological and non-pharmacological interventions. First-line pharmacological treatments include amitriptyline, a tricyclic antidepressant, shown to be effective in reducing headache frequency and intensity. Other effective options include other tricyclic antidepressants, mirtazapine, venlafaxine, and topiramate. Non-pharmacological approaches are crucial and should be considered in conjunction with or as alternatives to medication. These include behavioral therapies such as relaxation training, biofeedback, and cognitive behavioral therapy (CBT). These techniques can empower patients to manage stress, improve coping mechanisms, and reduce headache triggers. Consider implementing lifestyle modifications such as regular exercise, adequate sleep hygiene, and stress reduction techniques as part of a comprehensive treatment plan. Explore how integrating patient education on headache triggers, proper medication usage, and self-management strategies can enhance treatment outcomes. Learn more about the evidence supporting the effectiveness of combination therapy for CTTH.

Referral to a specialist, such as a neurologist or headache specialist, is warranted in several scenarios involving chronic headache. These include cases where the diagnosis is uncertain, especially when differentiating between chronic migraine, chronic tension-type headache, and other headache disorders like medication-overuse headache. Referral is also indicated if the headache is refractory to initial treatment strategies, exhibits red flags suggestive of a secondary headache disorder (e.g., sudden onset thunderclap headache, headache with neurological deficits, headache worsening with Valsalva maneuver), or if the headache significantly impacts the patient's quality of life and daily functioning. Consider referral if diagnostic testing is needed to rule out secondary causes, if the patient requires specialized treatment modalities like botulinum toxin injections or nerve blocks, or if comorb psychiatric disorders complicate management. Explore how establishing a collaborative care pathway with specialists can ensure comprehensive and coordinated care for patients with complex chronic headache. Learn more about the criteria for referral outlined by professional organizations like the American Headache Society and the National Headache Foundation.